NCT Number: NCT02200068
CARNet : Self-Monitoring and Co-driving in Rheumatology With Internet : Rheumatoid Arthritis Cohort (Usual Care Study)
Recommendations of Rheumatoid Arthritis management agree on the necessity of patient self-involvement in the care. In parallel, the observation of the adoption rate of websites directed toward patients may indicate that this involvement is shared by a large number ot the population.
However, most of these sites are only informative and few of them offer patients to be engaged to generate their own data that can impact on the patient-physician relationship by easing the dialog and then leading to better mutual understanding.
As new web or mobile services allowing patients to self-report their outcomes are flourishing only a very few of them have already addressed the their impact of the patient-physician relationship.
The main objective of this study is to quantify the effect of a website (Sanoia) on the quality of patient-doctor interactions, as perceived by the patient using the french translations of the Peppi Questionnaire during the 12 months observation period.
In France, the patient protection committee (CPP) has ranked this study in "Soins Courants" (Usual Care).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
University Hospital Jean Minjoz, Besançon, France
About this study
Recommendations of care in rheumatoid arthritis (RA) advocate for patient involvement and management of his/her own health.
The observation of the sole rate of use of websites specialized health patients might indicate that this involvement is occurring for a large number. Indeed, yet in 2010, more than 71% of French Netizen used the Internet to search for information related to their health according to a 2012 survey from the French National Order of Medical Doctors. Focusing on rheumatology, 68% of French patients have already used the Internet to search for information related to their arthritis as shown from a 2012 survey of the French Society of Rheumatology. In this medical field, these results reflect the fact that in France since years 2000, patients' associations and institutions, edited websites to offer patients a direct and easier access to information on diseases or treatments.
Nevertheless, it is useful to observe the type of service provided to the patient on these sites: the majority of these sites, even the most recent offer only the dissemination of information and never have been studied on this informative nature. These sites should be considered as an introductory step toward patient involvement.
Indeed, patients involvement is effective if they are really "active" and produce data, e.g. when him(her)self notes personal information online, manages a 'health book' virtual or self-assessing internet. In other words, involvement makes sense when it contributes to an "improvement" doctor-patient exchanges and when at last it leads to an increase in entropy.
Especially the latter type of use, i.e. the patient self-reported measure (patient-reported outcomes), can be a manner to both involve the patient in his care, and to feed the medical decision support with the certified rheumatologist. Moreover, it appears that the self-measurements in particular by the RA patient, are reliable.
In recent years, new services on the web or mobile begun to address this need and allowed patients to report issues relating to their health (current treatments, etc..), and to perform self-measures (pain, activity, morning stiffness, etc..). Notwithstanding visibility increasingly strong, it is striking to note that these tools, including those for self-measurement, have been little evaluated in terms of impact, for example on doctor-patient exchanges.
Indeed, Investigators have chosen to measure the characteristics of these exchanges, as perceived by the patient: effectiveness, quality and overall quality of care using dedicated tools.
In France, the patient protection committee (CPP) has ranked this study in "Soins Courants" (Usual Care).
The study will use the web-based platform (*) Sanoia.com, partner of the French Society of Rheumatology, which provides a trusted environment to its users via anonymity. This platform is recognized as innovative by the French Ministry of Research and relies on a data hosting architecture approved by the Ministry of Health. The statistical analysis of users data is limited to research purposes and placed under the dual supervision of patient associations and medical societies. These features are the source of its success in terms of audience with patients (> 145,000 health records created in September 2012).
Specifically Sanoia offers, among other benefits, Rheumatoid Arthritis (RA) patients to list their medical history and access to tools for self-measures, whether generic (e.g. notepad symptoms, followed by medications taken, etc.), or more specific to RA (e.g. RAPID3: routine assessment of patient index data, Health Assessment Questionnaire, Rheumatoid Arthritis Impact of Disease (RAID) score. Based on these data, a customized selection of information (based on an Internet monitoring performed by patient association ANDAR and validated by the medical society SFR) is displayed.
The main objective of this study is to quantify with RA patients the effect of a website (Sanoia) on the quality of patient-doctor interactions, as perceived by the patient using the french translations of the physician investigator to investigate the perceived efficacy ot the patient-physician relationship (PEPPI) Questionnaire during the 12 months observation period.
(*) : SANOIA is a personal health record platform that does not embed or to connect to social networks.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Adult over 18 years.
- Patient with Rheumatoid Arthritis diagnosed according to American College of Rheumatology (ACR ) / European League Against Rheumatism (EULAR) 2010 criteria.
- Patient monitored by the recruiting physician from over a year.
- Patient access who have access to an Internet broadband equipment other than on a mobile or a a smartphone
Exclusion criteria
- Patient already using Sanoia at the time of inclusion.
- Patient already participating in a therapeutic clinical trial in rheumatology
- Patient having no computer literacy and understanding difficulties
Treatment and study plan
Primary outcomes
-
Change from Baseline to 12 months after inclusion of Perceived efficacy by the patient of patient-physician interactions (PEPPI)
Time frame: Baseline and Month 12
Patients connects to the electronic Case Report Form (e-CRF) and file the French translation of the 5-item PEPPI Questionnaire
Secondary outcomes
-
Rheumatoid Arthritis Impact of Disease (RAID) score
Time frame: Baseline, Month 3, Month 6 and Month 12
Patients connects to the e-CRF and file the French translation of the Rheumatoid Arthritis Impact of Disease (RAID) score
-
Overall assessment of the patient's Health as measured by a VAS
Time frame: Baseline, Month 3, Month 6 and Month 12
Patients connects to the e-CRF and move a cursor on the appropriate value on a Visual Analogic Scale
-
Patient-Physician communication quality, as assessed by the patient using a Numeric Rating Scale
Time frame: Baseline, Month 3, Month 6 and Month 12
Patients connects to the e-CRF and selects the appropriate number on a Numeric Rating scale
-
Overall perceived quality of care, as assessed by the patient via a Numeric Rating Scale
Time frame: Baseline, Month 3, Month 6 and Month 12
Patients connects to the e-CRF and selects the appropriate number on a Numeric Rating scale
-
Number of patient's visits to the Rheumatologist from baseline to 12 months after inclusion
Time frame: Month 3, Month 6 and Month 12
Patient reports the number of visits to the Rheumatologist
-
Satisfaction of SANOIA using a Numeric Rating Scale for the PHR Group
Time frame: Month 3 and Month 12
Patients connects to the e-CRF and selects the appropriate number on a Numeric Rating scale
-
Unsatisfactory criteria using a pre-defined list for the PHR Group
Time frame: Month 3 and Month 12
Patients connects to the e-CRF and selects the appropriate items in a list of pre-defined criteria
-
Spontaneous access and use of SANOIA for Non-PHR Group (usual care)
Time frame: Month 12
Time period and origin of access of Group 2 Patients (usual care) that incidentally used SANOIA prior or during the study
-
Health Assessment Quality of Life Disability Index Questionnaire
Time frame: Baseline
Patients connects to the e-CRF and file the French translation of the Health Assessment Quality of Life Disability Index Questionnaire
-
Co-morbidities list
Time frame: Baseline
Patients connects to the e-CRF and file the French translation of the 15 item (12 compulsory answers and 3 additional open items) of an adapted Comorbidities Questionnaire
Other outcomes
-
Value of Perceived efficacy by the patient of patient-physician interactions (PEPPI)
Time frame: Month 3 and Month 6
Patients connects to the electronic Case Report Form (e-CRF) and file the French translation of the 5-item PEPPI Questionnaire
Sponsors and collaborators
Lead sponsor
Association Accompagnement pour un Internet en Médecine et Santé au Service des Usagers
Other
Collaborators
- UCB France S.A.
Registry information
Official study title
Usual Care Randomized Study Measuring the Impact of an Online Personal Health Record (Sanoia) in Rheumatoid Arthritis Patients on Reported Outcomes
Acronym: CARNet
Important dates
- Study start
- 2014
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Jul 25, 2014
- Registry last updated
- Jun 20, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Dietary Salt in Rheumatoid Arthritis
NCT03649178
Arthritis, Arthritis, Rheumatoid
Nashville, Tennessee, United States
View Trial DetailsLong Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
NCT03025308
Arthritis, Arthritis, Rheumatoid
Huntsville, Alabama, United States
View Trial DetailsUmbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid Arthritis: A Randomized Double-Blind Placebo-Controlled Trial
NCT07715045
Arthritis, Arthritis, Rheumatoid
Palembang, South Sumatera, Indonesia
View Trial DetailsStudy of Families With Twins or Siblings Discordant for Rheumatic Disorders
NCT00055055
Arthritis, Arthritis, Rheumatoid
Bethesda, Maryland, United States
View Trial Details